Pradžia › Kraujo krešuliai › Tennessee
Kraujo krešuliai klinikiniai tyrimai Tennessee
7 tyrimai dėl Kraujo krešuliai ieško dalyvių vietose Tennessee.
Miestai Tennessee
Oficialus tyrimo tekstas (anglų kalba)
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Tennessee Center for Clinical Trials, Tullahoma
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- East Coast Institute for Research, Jefferson City, Jefferson City
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07175428Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Apex Research Foundation, LLC, Jackson
- Tennova TCMC, Knoxville
- Vanderbilt Heart and Vascular Tullahoma, Cardiology and Vascular Associates, Tullahoma
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07318610Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Tennessee Center for Clinical Trials, Tullahoma
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT07430956ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- St. Jude Children's Research Hospital, Memphis
- Vanderbilt University Medical Center, Nashville
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-17 · NCT04398628Rapid Evacuation and Access of Cerebral Hemorrhage Trial
- Vanderbilt University Medical Center, Nashville
Renkami dalyviai
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-08-14 · NCT06870812Neonatal Platelet Transfusion Threshold Trial
- Vanderbilt University, Nashville
Renkami dalyviaiLaukiami sveiki savanoriai
1 Hour – 48 Hours · Visoms lytims · Atnaujinta 2026-03-25 · NCT06676904Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.